Map Home
Type / to search with text or keywords
/
keyboard shortcut: Type "/" on your keyboard for a quick search
Search button
Loading...
Loading...
Scroll left
Grants
Citations
H-Index
Patents
News
Books
Scroll right
Collapse sidebar
Data issues & feedback
Adjust height of sidebar
KMap
People
Adjust height of sidebar
KMap
Profile
Ravitharan Krishnadasan
Clinical Professor, Medicine - (Clinical Series Track)
Medicine
Overview
Research
More
Collaboration
(17)
Denise Roe
Mutual work: 1 Proposal
Collaboration Details
Megha Padi
Mutual work: 1 Proposal
Collaboration Details
Richard Simpson
Mutual work: 1 Proposal
Collaboration Details
Emmanuel Katsanis
Mutual work: 1 Grant﹒1 Proposal
Collaboration Details
Michele Chu-Pilli
Mutual work: 6 Proposals﹒4 Grants
Collaboration Details
Page 1 of 4
Previous page
Next page
Grants
(25)
A Phase 3 Randomized Study Comparing Talquetamab SC in Combination With Daratumumab SC and Pomalidomide (Tai-DP) or Talquetamab SC in Combination With Daratumumab SC (Tal-D) Versus Daratumumab SC, Pom
Active
·
2023
·
$0 / $546.3K
·
External
Co-Investigator (COI)
clinical trials,
immunotherapy,
multiple myeloma,
combination therapy,
drug development
A Phase 1, Multicenter, Open-Label Study of CB-010, a CRISPR-Edited Allogeneic Anti-CD19 CAR-T Cell Therapy in Patients with Relapsed/Refractory B Cell Non-Hodgkin Lymphoma (ANTLER)
Active
·
2023
·
$0 / $464.7K
·
External
Co-Investigator (COI)
cell therapy,
cancer treatment,
crispr,
lymphoma,
clinical trial
An Escalation/Expansion, Open Label, Multicenter Study of Iadademstat and Gilteritnib in Patients With Relapsed or Refractory Acute Myeloid Leukemia (R/r Amil) With FMS-like Tyrosine Mutation (FLT3 mu
Active
·
2023
·
$0 / $116.3K
·
External
Co-Investigator (COI)
acute myeloid leukemia,
mutation,
combination therapy,
treatment
A Randomized, Open Label Phase 3 Study Evaluating Safety and Efficacy of Venetoclax in combination with Azacitidine after allogeneic Stem Cell Transplantation in Subjects with Acute Myeloid Leukemia
Active
·
2022
·
$0 / $2.4M
·
External
Co-Investigator (COI)
stem cell transplantation,
acute myeloid leukemia,
venetoclax,
azacitidine,
efficacy and safety
Regional Hemophilia Network - Mountain States
Active
·
2022
·
$90K
·
External
Principal Investigator (PI)
hemophilia,
healthcare,
regional networks,
medical services,
public health
Page 1 of 5
Previous page
Next page
Publications
(10)
Recent
A phase 1b study of venetoclax and azacitidine combination in patients with relapsed or refractory myelodysplastic syndromes
2022
cancer,
myelodysplastic,
drug combination,
clinical trial,
therapy
Hemolytic Anemias: Autoimmune and Beyond
2021
hemolytic anemias,
autoimmune,
blood disorders,
immune system,
genetic disorders
Implementation of a pharmacy-managed program for the transition of chemotherapy to the outpatient setting
2018
pharmacy management,
chemotherapy transition,
outpatient care,
healthcare program,
oncology services
Diagnosis and Treatment of Benign Bleeding Disorders
2016
hematology,
blood disorders,
diagnosis,
treatment,
medical
Case of relentless chronic phase of chronic myeloid leukaemia
2016
leukaemia,
treatment,
disease progression,
oncology
Retrospective review of intravenous pentamidine for Pneumocystis pneumonia prophylaxis in allogeneic hematopoietic stem cell transplantation
2015
pneumocystis pneumonia,
intravenous pentamidine,
hematopoietic stem cell transplantation,
retrospective review,
prophylaxis
ATRA-Associated Marrow Necrosis in a Patient With Acute Promyelocytic Leukemia: A Case Presentation and Review of the Literature
2015
leukemia,
necrosis,
case presentation,
literature review,
atra
Almost bleeding to death the conundrum of acquired amegakaryocytic thrombocytopenia
2014
thrombocytopenia,
acquired,
amegakaryocytic,
bleeding,
conundrum
Heart of lymphoma: primary mediastinal large B-cell lymphoma with endomyocardial involvement
2013
lymphoma,
cardiology,
cancer,
oncology,
mediastinal
Overexpression of SOCS3 is associated with decreased survival in a cohort of patients with de novo follicular lymphoma
2006